Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed/Refractory Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01827605
What this trial is testing

A Phase III Multicenter, Randomized Study Comparing RIT Vs ASCT in Patients With Relapsed/Refractory (FL)

Who this might be right for
Relapsed Follicular Lymphoma
Fondazione Italiana Linfomi - ETS 159
Early research (Phase 1)Ended earlyNCT03755154
What this trial is testing

Study of a New Intravenous Drug, Called S65487, in Patients With Acute Myeloid Leukemia, Non Hodgkin Lymphoma, Multiple Myeloma or Chronic Lymphocytic Leukemia

Who this might be right for
Relapsed or Refractory Acute Myeloid LeukemiaRelapsed or Refractory Non-Hodgkin LymphomaRelapsed or Refractory Multiple Myeloma+1 more
Institut de Recherches Internationales Servier 60
Testing effectiveness (Phase 2)Study completedNCT00304005
What this trial is testing

VNP40101M in Treating Patients With Richter Syndrome or Refractory or Relapsed Chronic Lymphocytic Leukemia or Other Lymphoproliferative Disorders

Who this might be right for
LeukemiaLymphoma
Vion Pharmaceuticals 35
Very early researchLooking for participantsNCT05800405
What this trial is testing

Evaluation of Bridging Radiation Therapy Before CAR T-Cell Infusion for the Treatment of Relapsed or Refractory Large B-Cell Lymphoma

Who this might be right for
Recurrent Diffuse Large B-Cell LymphomaRefractory Diffuse Large B-Cell Lymphoma
City of Hope Medical Center 9
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07441954
What this trial is testing

Pomalidomide Combined With Obinutuzumab in the Treatment of Patients With Relapsed/Refractory Indolent Lymphoma

Who this might be right for
Indolent Lymphoma
Institute of Hematology & Blood Diseases Hospital, China 53
Testing effectiveness (Phase 2)Study completedNCT00005854
What this trial is testing

Bone Marrow Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT03356054
What this trial is testing

Phase I-II Study in CD30 Positive Diffuse Large B-cell Lymphoma Patients Refractory to First Line Chemotherapy or in First Relapse

Who this might be right for
DLBCL
Stichting Hemato-Oncologie voor Volwassenen Nederland 37
Testing effectiveness (Phase 2)Ended earlyNCT00493454
What this trial is testing

Ibritumomab Tiuxetan for Treatment of Non-Follicular CD20+ Indolent Lymphomas

Who this might be right for
Lymphoma
M.D. Anderson Cancer Center 6
Testing effectiveness (Phase 2)UnknownNCT06224842
What this trial is testing

Clinical Study of Mitoxantrone Liposome and Azacitidine in the Treatment of R/R AITL

Who this might be right for
Angioimmunoblastic T-cell Lymphoma
Huijing Wu 30
Testing effectiveness (Phase 2)Looking for participantsNCT05674175
What this trial is testing

Co-administration of CART22-65s and huCART19 for B-ALL

Who this might be right for
B-cell Acute Lymphoblastic LeukemiaB Lineage Lymphoblastic Lymphoma
Stephan Grupp MD PhD 93
Testing effectiveness (Phase 2)Study completedNCT04323657
What this trial is testing

TC-110 T Cells in Adults With Relapsed or Refractory Non-Hodgkin Lymphoma or Acute Lymphoblastic Leukemia

Who this might be right for
Non Hodgkin LymphomaAcute Lymphoblastic LeukemiaDiffuse Large B Cell Lymphoma+3 more
TCR2 Therapeutics 6
Testing effectiveness (Phase 2)Looking for participantsNCT06553872
What this trial is testing

Phase 2 Open Label Randomized Study of Pirtobrutinib and Brexucabtagene Autoleucel in R/R MCL

Who this might be right for
Mantle Cell Lymphoma
H. Lee Moffitt Cancer Center and Research Institute 60
Early research (Phase 1)UnknownNCT05210907
What this trial is testing

Clinical Study of Hospital-manufactured CD19 CAR-T in Children and Adolescents With Acute Lymphoblastic Leukemia

Who this might be right for
B-cell Acute Lymphoblastic Leukemia
Seoul National University Hospital 5
Early research (Phase 1)Study completedNCT01567709
What this trial is testing

Alisertib in Combination With Vorinostat in Treating Patients With Relapsed or Recurrent Hodgkin Lymphoma, B-Cell Non-Hodgkin Lymphoma, or Peripheral T-Cell Lymphoma

Who this might be right for
Adult B Acute Lymphoblastic LeukemiaAdult T Acute Lymphoblastic LeukemiaAnaplastic Large Cell Lymphoma+32 more
National Cancer Institute (NCI) 34
Testing effectiveness (Phase 2)WithdrawnNCT03719898
What this trial is testing

Brigatinib in Relapsed or Refractory ALK-Positive Anaplastic Large Cell Lymphoma

Who this might be right for
Anaplastic Large Cell Lymphoma, ALK-Positive
Fox Chase Cancer Center
Not applicableNot Yet RecruitingNCT07472621
What this trial is testing

Real-World Effectiveness and Safety of Glofitamab in Primary Refractory and Early Relapsed Diffuse Large B-Cell Lymphoma

Who this might be right for
DLBCL - Diffuse Large B Cell Lymphoma
Henan Cancer Hospital 20
Testing effectiveness (Phase 2)Study completedNCT00684411
What this trial is testing

Gleevec in Relapsed/Refractory T Cell Non-Hodgkin's Lymphoma

Who this might be right for
T Cell Non-Hodgkin Lymphoma
Dana-Farber Cancer Institute 12
Not applicableEnded earlyNCT00062231
What this trial is testing

Moxifloxacin Compared With Ciprofloxacin/Amoxicillin in Treating Fever and Neutropenia in Patients With Cancer

Who this might be right for
Chronic Myeloproliferative DisordersFever, Sweats, and Hot FlashesInfection+8 more
European Organisation for Research and Treatment of Cancer - EORTC 351
Testing effectiveness (Phase 2)Study completedNCT00540007
What this trial is testing

Lenalidomide in Relapsed or Refractory Classical Hodgkin Lymphoma

Who this might be right for
Hodgkin Disease
Washington University School of Medicine 80
Testing effectiveness (Phase 2)WithdrawnNCT02285244
What this trial is testing

Sotrastaurin Acetate in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia, Prolymphocytic Leukemia, or Richter's Transformation

Who this might be right for
Prolymphocytic LeukemiaRecurrent Mantle Cell LymphomaRecurrent Small Lymphocytic Lymphoma+2 more
James Blachly
Next Page